In 41 patients treated with ipilimumab, 34.1% developed cutaneous adverse events that included rash (7.3%), folliculitis (7.3%), mucositis (2.4%), rosacea (2.4%), eczema (2.4%), acneiform eruption (2.4%), syringometaplasia mucinosa (2.4%;), Stevens-Johnson syndrome (2.4%), and vitiligo (4.9%)
Cancer patients receiving chemotherapy need special consideration, as glutathione can interfere with certain cancer treatments
In a redox-balanced state, a lower concentration of ROS activates endogenous defense mechanisms, leading to coordinated activation of antioxidant genes
Nishinaka T et al
Its one of the most popular peptides in performance medicine, longevity therapy, and musculoskeletal regeneration